| Fournel, Pierre |
ELDERLY, NCT03977194: Atezolizumab in Elderly Patients With Advanced Non-Small-Cell Lung Cancer and Receiving Carboplatin Paclitaxel Chemotherapy |
|
|
| Active, not recruiting | 3 | 500 | Europe | Carboplatin, Paclitaxel, Atezolizumab | Intergroupe Francophone de Cancerologie Thoracique | Non Small Cell Lung Cancer Metastatic | 12/24 | 12/26 | | |
| Recruiting | 3 | 600 | Europe | Standard of care + chemotherapy, Standard of care | Institut Claudius Regaud, Direction Générale de l’Offre de Soins (DGOS) | Soft Tissue Sarcoma | 10/32 | 10/32 | | |
DIAL, NCT05255302 / 2021-006044-27: De-escalation Immunotherapy MAintenance Duration Trial for Stage IV Lung Cancer Patients with Disease Control After Chemo-immunotherapy Induction |
|
|
| Recruiting | 2/3 | 1360 | Europe | Pembrolizumab before randomization, Chemotherapy, Pemetrexed, Pembrolizumab after randomization | Intergroupe Francophone de Cancerologie Thoracique, IFCT | Metastatic NSCLC | 01/25 | 06/29 | | |
ADAPTABLE, NCT05781308: Combination of Paclitaxel-bevacizumab ± Atezolizumab in Patients with Advanced NSCLC Progressing After Immunotherapy & Chemotherapy |
|
|
| Active, not recruiting | 2 | 156 | Europe | Paclitaxel, Bevacizumab, Avastin, Atezolizumab, Tecentriq | Intergroupe Francophone de Cancerologie Thoracique | Non Small Cell Lung Cancer | 09/25 | 06/26 | | |
PARACT, NCT03240341: Influence of PARAmedical Interventions on Patient ACTivation in the Cancer Care Pathway |
|
|
| Completed | N/A | 600 | Europe | Patient Activation Measure Questionnaire | Centre Hospitalier Universitaire de Saint Etienne, Hôpital Privé de la Loire, Centre Hospitalier Emile Roux, Clinique de l'infirmerie protestante de Lyon, Institut de Cancérologie de la Loire | Cancer | 10/21 | 10/22 | | |
PROFILER, NCT01774409: Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer |
|
|
| Recruiting | N/A | 10000 | Europe | Blood and tumor samples | Centre Leon Berard | Neoplasms | 07/25 | 07/26 | | |
| Recruiting | N/A | 900 | Europe | | Centre Leon Berard | Carcinoma, Non-Small-Cell Lung | 03/26 | 12/26 | | |
| Recruiting | N/A | 4975 | Europe, RoW | RP-1828 IMMUcan, RP-1759 AYA/TYA, RP-1843 Arcagen, RP-1920 BioRadon | European Organisation for Research and Treatment of Cancer - EORTC | All Tumor Types | 03/26 | 03/26 | | |
| Recruiting | N/A | 168 | Europe | Treatment by Regorafenib, Stivarga, Treatment by Placebo, Standard of care | Centre Leon Berard | Bone Sarcoma, Osteosarcoma, Ewing Sarcoma, Chondrosarcoma, Undifferentiated Pleomorphic Sarcoma, Leiomyosarcoma, Angiosarcoma | 10/26 | 10/26 | | |
| Active, not recruiting | N/A | 413 | Europe | Quality of Life Questionnaire-Core 30 (QLQ-C30), Quality of Life Questionnaire-Lung Cancer 13 (QLQ-LC13), 5-level EuroQoL EQ5D (EQ5D-5L) | Groupe Francais De Pneumo-Cancerologie, AstraZeneca | Non-Small Cell Lung Cancer | 06/27 | 06/27 | | |
